Avantor (AVTR) vs Bruker (BRKR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bruker (BRKR) has outperformed Avantor (AVTR) over the past year, gaining 72.8% versus a gain of 14.0%. Over five years, BRKR leads with a -22.7% price change compared with -60.0% for AVTR. Avantor is the larger company by market cap ($10.27 billion vs $8.80 billion), about 1.2 times the size, while Bruker is growing revenue faster (+2.1% vs -3.4%).
On valuation, Avantor trades at a lower forward P/E (17.3x vs 24.0x for Bruker). Bruker pays a dividend yielding 0.35%, while Avantor does not currently pay one. Bruker converts more of its revenue into profit, with a net margin of -0.3% versus -8.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVTR | BRKR |
|---|---|---|
| Share price | $15.19 | $57.78 |
| Market cap | $10.27B | $8.80B |
| 1-day change | -1.07% | -3.25% |
| YTD return | +33.94% | +26.77% |
| 1-year return | +13.96% | +72.80% |
| 5-year return | -59.97% | -22.67% |
| Forward P/E | 17.31 | 23.95 |
| EPS (TTM) | $-0.84 | $-0.70 |
| Dividend yield | 0.00% | 0.35% |
| Annual dividend | $0.00 | $0.20 |
| Revenue (latest FY) | $6.55B | $3.44B |
| Revenue growth (YoY) | -3.41% | +2.08% |
| Net income (latest FY) | $-530.20M | $-8.60M |
| Gross margin | 32.65% | 45.91% |
| Operating margin | -3.76% | 1.98% |
| Net margin | -8.09% | -0.25% |
| 52-week high | $16.38 | $66.98 |
| 52-week low | $7.27 | $32.37 |
| Distance from 52-week high | -7.27% | -13.74% |
| Analyst consensus | hold | buy |
| Avg. price target upside | -2.67% | +9.47% |
| Average volume | 9.43M | 2.23M |
| Shares outstanding | 676.36M | 152.36M |
| Employees | 13,500 | 11,085 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BRKR has outperformed AVTR by 58.8 percentage points over the past year.
- Bruker is more profitable, keeping -0.3 cents of every revenue dollar as net income versus -8.1 cents for Avantor.
- Bruker grew revenue faster in its latest fiscal year (+2.08% vs -3.41%).
About Avantor
AVTR stock →Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Industrials · Biotechnology: Laboratory Analytical Instruments · 13,500 employees
About Bruker
BRKR stock →Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,085 employees
AVTR vs BRKR FAQ
Which is bigger, Avantor or Bruker?
Avantor (AVTR) is larger, with a market capitalization of $10.27B compared with $8.80B for Bruker (BRKR).
Which stock has performed better over the past year, AVTR or BRKR?
BRKR returned +72.80% over the past 12 months, compared with +13.96% for AVTR (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Avantor or Bruker?
Bruker pays a dividend yielding 0.35%, while Avantor does not currently pay a regular dividend.
Are Avantor and Bruker in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.